Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2010-08-25 Transaction in Own Shar…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' submitted to the ASX. It details the number of shares bought back, total consideration paid, participation by directors, and compliance statements. The content focuses on the company's share repurchase activity rather than financial results, management changes, or regulatory certifications. The document length is short (2239 characters) and it is a formal notice of share buy-back activity. This matches the description of 'Transaction in Own Shares' filings, which report on company buybacks or sales of its own shares. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2010-08-25 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and contains detailed information about changes in securities holdings by a company director, including dates, number of shares/options held before and after the change, and transaction details. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure related to insider trading or director share transactions. The content is focused on personal share transactions by a director rather than broader company financials or management changes. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is about 3091 characters, which is typical for such notices and not a full financial report or announcement of a report. Therefore, the correct classification is DIRS.
2010-08-23 English
Appendix 4E and Form 10-K 105 pages ?Kb
Annual Report Classification · 100% confidence The document contains a detailed financial report for the fiscal year ended June 30, 2010, including consolidated statements of financial performance, position, and cash flows. It references the Form 10-K multiple times, which is the official annual report filed with the SEC. The presence of comprehensive financial data, management discussion references, and audit statements confirms this is the full annual report. The document is approximately 15,000 characters, indicating it is not a brief announcement or certification. Therefore, the document is classified as an Annual Report (10-K). FY 2010
2010-08-17 English
ResMed Stock conversion press release 1 page ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is an announcement from ResMed regarding a stock split and the deferral of conversions related to the stock split on the NYSE and ASX. It discusses waiver of specific ASX rules, dates for record holders, distribution of additional shares, and trading details post-split. There is no financial data, no detailed report, no earnings information, no management discussion, and no regulatory certification. The document is short (2952 characters) and serves as a market announcement about capital structure changes specifically related to a stock split and share issuance. This fits the category of Share Issue/Capital Change (SHA).
2010-08-12 English
ASX Circular - 2 for 1 Stock Split 1 page ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is an ASX Circular dated 11 August 2010 announcing a 2-for-1 stock split by ResMed Inc. It includes a timetable for the stock split events and references a prior announcement by the Board of Directors approving the split. The document is short (2235 characters) and serves as an announcement of a capital change event rather than a detailed report or financial statement. There is no financial data or detailed analysis, only the announcement and timetable of the stock split. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2010-08-10 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y' and is a 'Change of Director's Interest Notice' under ASX listing rule 3.19A.2. It details the change in securities holdings of a director, including the number of shares and options disposed and held before and after the change. The document is a formal notification of insider trading activity by a company director, which aligns with the definition of Director's Dealing filings. There is no financial report, earnings data, or management discussion present. The document is about a director's personal share transactions, which fits the 'Director's Dealing' category.
2010-08-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.